Hopes for a first wave of vaccinations before the end of 2020 are boosted after US firm Moderna said it is applying for an emergency authorization for the COVID-19 vaccine in the US and Europe on Monday.

After leading US scientists warned Americans to prepare for “burst superimposed on burst,” Moderna said the full results confirmed an efficiency estimated at 94.1 percent.

She was supposed to join US pharmaceutical maker Pfizer and Germany's BioNTech, which applied for similar approvals last week and predict their vaccine could receive the green light in the US shortly after December 10..

If the FDA agrees that Moderna is safe and effective, the first of two doses of the drug could be administered by mid-December.

“We believe our vaccine will be a powerful new tool that can change the course of this pandemic,” said Moderna CEO Stefan Bansel..

Health Minister Alex Azar told CBS News:.

"

The vaccine, co-developed with the US National Institutes of Health, was generally well tolerated. Side effect symptoms:

pain at the injection site, fatigue, muscle pain, joint pain, headache.

Moderna expects twenty million doses of a vaccine called mRNA-1273 will be available in the US by the end of the year, and between 500 million and a billion doses worldwide in 2021.. The news comes after leading American scientist Anthony Fauci voiced his fears that millions of travelers have returned home after the holiday..

https: // www. medikforum. ru /.

Keywords:.